377 related articles for article (PubMed ID: 38339149)
1. Gut Symptoms, Gut Dysbiosis and Gut-Derived Toxins in ALS.
Lee A; Henderson R; Aylward J; McCombe P
Int J Mol Sci; 2024 Feb; 25(3):. PubMed ID: 38339149
[TBL] [Abstract][Full Text] [Related]
2. Gut microbiota in ALS: possible role in pathogenesis?
McCombe PA; Henderson RD; Lee A; Lee JD; Woodruff TM; Restuadi R; McRae A; Wray NR; Ngo S; Steyn FJ
Expert Rev Neurother; 2019 Sep; 19(9):785-805. PubMed ID: 31122082
[No Abstract] [Full Text] [Related]
3. Gut-Modulating Agents and Amyotrophic Lateral Sclerosis: Current Evidence and Future Perspectives.
Noor Eddin A; Alfuwais M; Noor Eddin R; Alkattan K; Yaqinuddin A
Nutrients; 2024 Feb; 16(5):. PubMed ID: 38474719
[TBL] [Abstract][Full Text] [Related]
4. Lessons to Learn from the Gut Microbiota: A Focus on Amyotrophic Lateral Sclerosis.
Calvo AC; Valledor-Martín I; Moreno-Martínez L; Toivonen JM; Osta R
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627250
[TBL] [Abstract][Full Text] [Related]
5. Potential Role of the Gut Microbiome in ALS: A Systematic Review.
Wright ML; Fournier C; Houser MC; Tansey M; Glass J; Hertzberg VS
Biol Res Nurs; 2018 Oct; 20(5):513-521. PubMed ID: 29925252
[TBL] [Abstract][Full Text] [Related]
6. Gut- and oral-dysbiosis differentially impact spinal- and bulbar-onset ALS, predicting ALS severity and potentially determining the location of disease onset.
Kim HS; Son J; Lee D; Tsai J; Wang D; Chocron ES; Jeong S; Kittrell P; Murchison CF; Kennedy RE; Tobon A; Jackson CE; Pickering AM
BMC Neurol; 2022 Feb; 22(1):62. PubMed ID: 35189854
[TBL] [Abstract][Full Text] [Related]
7. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS).
Boddy SL; Giovannelli I; Sassani M; Cooper-Knock J; Snyder MP; Segal E; Elinav E; Barker LA; Shaw PJ; McDermott CJ
BMC Med; 2021 Jan; 19(1):13. PubMed ID: 33468103
[TBL] [Abstract][Full Text] [Related]
8. A Gut Feeling in Amyotrophic Lateral Sclerosis: Microbiome of Mice and Men.
Martin S; Battistini C; Sun J
Front Cell Infect Microbiol; 2022; 12():839526. PubMed ID: 35360111
[TBL] [Abstract][Full Text] [Related]
9. Brain-Gut-Microbiota Axis in Amyotrophic Lateral Sclerosis: A Historical Overview and Future Directions.
Chen S; Cai X; Lao L; Wang Y; Su H; Sun H
Aging Dis; 2024 Feb; 15(1):74-95. PubMed ID: 37307822
[TBL] [Abstract][Full Text] [Related]
10. Gut inflammation and dysbiosis in human motor neuron disease.
Rowin J; Xia Y; Jung B; Sun J
Physiol Rep; 2017 Sep; 5(18):. PubMed ID: 28947596
[TBL] [Abstract][Full Text] [Related]
11. The fecal microbiome of ALS patients.
Brenner D; Hiergeist A; Adis C; Mayer B; Gessner A; Ludolph AC; Weishaupt JH
Neurobiol Aging; 2018 Jan; 61():132-137. PubMed ID: 29065369
[TBL] [Abstract][Full Text] [Related]
12. Unhealthy gut, unhealthy brain: The role of the intestinal microbiota in neurodegenerative diseases.
Spielman LJ; Gibson DL; Klegeris A
Neurochem Int; 2018 Nov; 120():149-163. PubMed ID: 30114473
[TBL] [Abstract][Full Text] [Related]
13. Gut dysbiosis, defective autophagy and altered immune responses in neurodegenerative diseases: Tales of a vicious cycle.
Chidambaram SB; Essa MM; Rathipriya AG; Bishir M; Ray B; Mahalakshmi AM; Tousif AH; Sakharkar MK; Kashyap RS; Friedland RP; Monaghan TM
Pharmacol Ther; 2022 Mar; 231():107988. PubMed ID: 34536490
[TBL] [Abstract][Full Text] [Related]
14. Amyotrophic lateral sclerosis and intestinal microbiota-toward establishing cause and effect.
Gotkine M; Kviatcovsky D; Elinav E
Gut Microbes; 2020 Nov; 11(6):1833-1841. PubMed ID: 32501768
[TBL] [Abstract][Full Text] [Related]
15. The Role of Short-Chain Fatty Acids in Microbiota-Gut-Brain Cross-Talk with a Focus on Amyotrophic Lateral Sclerosis: A Systematic Review.
Moțățăianu A; Șerban G; Andone S
Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37894774
[TBL] [Abstract][Full Text] [Related]
16. Potential role of gut microbiota and tissue barriers in Parkinson's disease and amyotrophic lateral sclerosis.
Fang X
Int J Neurosci; 2016 Sep; 126(9):771-6. PubMed ID: 26381230
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome and amyotrophic lateral sclerosis: A systematic review of current evidence.
Sun J; Huang T; Debelius JW; Fang F
J Intern Med; 2021 Oct; 290(4):758-788. PubMed ID: 34080741
[TBL] [Abstract][Full Text] [Related]
18. Assessment of bidirectional relationships between 98 genera of the human gut microbiota and amyotrophic lateral sclerosis: a 2-sample Mendelian randomization study.
Zhang L; Zhuang Z; Zhang G; Huang T; Fan D
BMC Neurol; 2022 Jan; 22(1):8. PubMed ID: 34979977
[TBL] [Abstract][Full Text] [Related]
19. A prospective longitudinal study on the microbiota composition in amyotrophic lateral sclerosis.
Di Gioia D; Bozzi Cionci N; Baffoni L; Amoruso A; Pane M; Mogna L; Gaggìa F; Lucenti MA; Bersano E; Cantello R; De Marchi F; Mazzini L
BMC Med; 2020 Jun; 18(1):153. PubMed ID: 32546239
[TBL] [Abstract][Full Text] [Related]
20. Amyotrophic Lateral Sclerosis Pathoetiology and Pathophysiology: Roles of Astrocytes, Gut Microbiome, and Muscle Interactions via the Mitochondrial Melatonergic Pathway, with Disruption by Glyphosate-Based Herbicides.
Anderson G
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614029
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]